Treatment News : Levitra Doesn’t Increase “Dizzy Spells” in Selzentry Takers

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » June 2010

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


June 25, 2010

Levitra Doesn’t Increase “Dizzy Spells” in Selzentry Takers

People who are on a Selzentry (maraviroc) HIV regimen don’t have an increased risk for orthostatic hypotension—which can lead to a head rush or dizzy spell—if they take the erectile dysfunction (ED) drug Levitra (vardenafil). These results were published in the July 1 issue of the Journal of Acquired Immune Deficiency Syndromes.

Though orthostatic hypotension—sudden drops in blood pressure upon standing—is not a common side effect of Selzentry, it can occur, and the resulting dizziness can lead to falls and injuries. Given the fact that ED drugs, including Levitra, Viagra (sildenafil) and Cialis (tadalafil), can also lower a person’s blood pressure, some providers have been recommending that people taking Selzentry use ED drugs with caution.

To determine the effect of Levitra on blood pressure in people taking Selzentry, Manoli Vourvahis, Pharm D, from Pfizer Global Research and Development in New London, Connecticut, and his colleagues studied 18 HIV-negative men on a steady dose of Selzentry who took either Levitra or a placebo at two time points.

Vourvahis’s team found no difference in the risk of orthostatic hypotension in people taking Levitra compared with those who took a placebo. Levitra was associated with more side effects than placebo, but these were all relatively minor and were well-known Levitra side effects, such as headache and nasal congestion.

Though the authors concluded that “this drug combination can be used safely,” they also warned that “caution is warranted when applying [these] findings to HIV-infected patients receiving antiretroviral therapy and/or antihypertensive medication.”

Search: Selzentry, maraviroc, erectile dysfunction, ED, Levitra, vardenafil, Viagra, sildenafil, Cialis, tadalafil, Manoli Vourvahis

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.